E92: Obesity Medicine: GLP-1s: Saxenda, Wegovy, Zepbound, and Foundayo episode artwork

EPISODE · Jul 20, 2026 · 50 MIN

E92: Obesity Medicine: GLP-1s: Saxenda, Wegovy, Zepbound, and Foundayo

from This Is Your Brain On Drugs Psychiatry Podcast

Today I will be covering the GLP1 medications. Starting with exenatide and dulaglutide and then covering liraglutide (Saxenda), semaglutide (Wegovy), tirzepatide (Zepbound), and orforglipron (Foundayo). I'll go over how they are different, which work better, which are better tolerated, how to customize them, how they compare, and when I would pick each one.

Episode metadata supplied by the publisher feed · Published Jul 20, 2026

Embed this episode

NOW PLAYING

E92: Obesity Medicine: GLP-1s: Saxenda, Wegovy, Zepbound, and Foundayo

0:00 50:23

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of This Is Your Brain On Drugs Psychiatry Podcast?

This episode is 50 minutes long.

When was this This Is Your Brain On Drugs Psychiatry Podcast episode published?

This episode was published on July 20, 2026.

Can I download this This Is Your Brain On Drugs Psychiatry Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!